These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 461277)

  • 21. [Live influenza virus vaccine].
    Shimizu K; Oguro M; Mukaigawa J
    Uirusu; 1984 Jun; 34(1):25-36. PubMed ID: 6382793
    [No Abstract]   [Full Text] [Related]  

  • 22. Immunogenicity of inactivated influenza vaccine, purified by adsorption chromatography on porous glas.
    Bresler S; Kolikov V; Katushkina N; Molodkin V; Friedman E; Zheleznova H; Malafeieva L; Peradze T; Beljakov V; Ivanov K
    Med Biol; 1975 Dec; 53(6):456-61. PubMed ID: 1214539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Slowing Influenza Virus Evolution: A Role for Multiple Synergistic Antiviral Specificities in Vaccination Strategies.
    Lafont BAP; Bennink JR
    Viral Immunol; 2020 Apr; 33(3):197-200. PubMed ID: 32286176
    [No Abstract]   [Full Text] [Related]  

  • 24. Universal influenza vaccines, science fiction or soon reality?
    de Vries RD; Altenburg AF; Rimmelzwaan GF
    Expert Rev Vaccines; 2015; 14(10):1299-301. PubMed ID: 26104835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influenza vaccine: an effective preventive vaccine for developing countries.
    Verma R; Khanna P; Chawla S
    Hum Vaccin Immunother; 2012 May; 8(5):675-8. PubMed ID: 22634439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The evolving history of influenza viruses and influenza vaccines.
    Hannoun C
    Expert Rev Vaccines; 2013 Sep; 12(9):1085-94. PubMed ID: 24024871
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of immunogenicity of cell-and egg-passaged viruses for manufacturing MDCK cell culture-based influenza vaccines.
    Shin D; Park KJ; Lee H; Cho EY; Kim MS; Hwang MH; Kim SI; Ahn DH
    Virus Res; 2015 Jun; 204():40-6. PubMed ID: 25892718
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influenza vaccines: challenges and solutions.
    Houser K; Subbarao K
    Cell Host Microbe; 2015 Mar; 17(3):295-300. PubMed ID: 25766291
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Influenza].
    Drescher HJ
    Arch Otorhinolaryngol Suppl; 1983; 1():113-87. PubMed ID: 6579922
    [TBL] [Abstract][Full Text] [Related]  

  • 30. From Original Antigenic Sin to the Universal Influenza Virus Vaccine.
    Henry C; Palm AE; Krammer F; Wilson PC
    Trends Immunol; 2018 Jan; 39(1):70-79. PubMed ID: 28867526
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Search for optimal scheme for administering live allantoic influenza vaccine.
    Zykov MP; Shaposhnikova RP; Vasil'eva RI; Subbotina TI; Rudenko LG; Gordon MA; Vakin VS
    J Hyg Epidemiol Microbiol Immunol; 1983; 27(4):419-24. PubMed ID: 6663074
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Challenges of selecting seasonal influenza vaccine strains for humans with diverse pre-exposure histories.
    Hensley SE
    Curr Opin Virol; 2014 Oct; 8():85-9. PubMed ID: 25108824
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Several hemagglutinins of same serotype for induction of broad immunity against influenza A virus antigenic drift variants: WO2008048984.
    Stech J
    Expert Opin Ther Pat; 2010 Mar; 20(3):447-50. PubMed ID: 20180625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Virus-specific T cells as correlate of (cross-)protective immunity against influenza.
    Altenburg AF; Rimmelzwaan GF; de Vries RD
    Vaccine; 2015 Jan; 33(4):500-6. PubMed ID: 25498210
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunoprophylaxis for influenza: comparison of a subunit and a whole virion vaccine.
    Carle F; Bolgiani M; Zanon P; Moiraghi Ruggenini A; Zotti C
    Boll Ist Sieroter Milan; 1988; 67(2):105-15. PubMed ID: 3067735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influenza virus-like particle can accommodate multiple subtypes of hemagglutinin and protect from multiple influenza types and subtypes.
    Pushko P; Pearce MB; Ahmad A; Tretyakova I; Smith G; Belser JA; Tumpey TM
    Vaccine; 2011 Aug; 29(35):5911-8. PubMed ID: 21723354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Patterns of change in the immunity of those inoculated with an inactivated chromatographic influenza vaccine on an annual basis].
    Mukhina LP; Bichurina MA; Rozaeva NR
    Tr Inst Im Pastera; 1983; 61():151-5. PubMed ID: 6678508
    [No Abstract]   [Full Text] [Related]  

  • 38. Mosaic H5 Hemagglutinin Provides Broad Humoral and Cellular Immune Responses against Influenza Viruses.
    Kamlangdee A; Kingstad-Bakke B; Osorio JE
    J Virol; 2016 Aug; 90(15):6771-6783. PubMed ID: 27194759
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Software for Characterizing the Antigenic and Genetic Evolution of Human Influenza Viruses.
    Reimering S; McHardy AC
    Methods Mol Biol; 2018; 1836():551-565. PubMed ID: 30151591
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The control of influenza.
    Mostow SR
    Am Rev Respir Dis; 1974 Nov; 110(5):542-4. PubMed ID: 4473948
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.